IGIV

A potential role for hepatitis B prophylaxis in the bone marrow peritransplant period

Johanna P. Daily, B. Werner, R. Soiffer, J. Fingeroth

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Prevention of hepatitis B virus infection in transplant recipients can be difficult. Patients may be unresponsive to vaccination and intolerant of the intramuscular injections required to administer hepatitis B immune globulin (HBIG). A recipient of HBsAg-positive donor cells for a bone marrow transplant received multiple i.m. injections of HBIG. This mode of antibody delivery was limited by his thrombocytopenia and neutropenia and alternative forms of passive immunization were sought. Four lots of IGIV were investigated for anti-hepatitis B surface antibody (anti-HBs) content and all were found to contain significant antibody titer. Moreover, IGIV that was administered to four bone marrow transplant recipients for medical purposes unrelated to HBV transmission produced protective anti-HBs titers in all. These studies suggest IGIV may be useful for HBV prophylaxis in the appropriate setting or if HBIG is unavailable. The optimum regimen for HBV prevention in distinct transplant settings needs to be determined.

Original languageEnglish (US)
Pages (from-to)739-742
Number of pages4
JournalBone Marrow Transplantation
Volume21
Issue number7
StatePublished - Apr 1 1998
Externally publishedYes

Fingerprint

Hepatitis B
Hepatitis B Antibodies
Immunoglobulins
Bone Marrow
Transplants
Passive Immunization
Antibodies
Intramuscular Injections
Virus Diseases
Hepatitis B Surface Antigens
Neutropenia
Hepatitis B virus
Bone Marrow Cells
Thrombocytopenia
Vaccination
Tissue Donors
Injections
Transplant Recipients

Keywords

  • Bone marrow transplant
  • HBIG
  • Hepatitis B virus
  • IGIV

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

IGIV : A potential role for hepatitis B prophylaxis in the bone marrow peritransplant period. / Daily, Johanna P.; Werner, B.; Soiffer, R.; Fingeroth, J.

In: Bone Marrow Transplantation, Vol. 21, No. 7, 01.04.1998, p. 739-742.

Research output: Contribution to journalArticle

@article{f5623900c1c0450a9414711cd7c66c78,
title = "IGIV: A potential role for hepatitis B prophylaxis in the bone marrow peritransplant period",
abstract = "Prevention of hepatitis B virus infection in transplant recipients can be difficult. Patients may be unresponsive to vaccination and intolerant of the intramuscular injections required to administer hepatitis B immune globulin (HBIG). A recipient of HBsAg-positive donor cells for a bone marrow transplant received multiple i.m. injections of HBIG. This mode of antibody delivery was limited by his thrombocytopenia and neutropenia and alternative forms of passive immunization were sought. Four lots of IGIV were investigated for anti-hepatitis B surface antibody (anti-HBs) content and all were found to contain significant antibody titer. Moreover, IGIV that was administered to four bone marrow transplant recipients for medical purposes unrelated to HBV transmission produced protective anti-HBs titers in all. These studies suggest IGIV may be useful for HBV prophylaxis in the appropriate setting or if HBIG is unavailable. The optimum regimen for HBV prevention in distinct transplant settings needs to be determined.",
keywords = "Bone marrow transplant, HBIG, Hepatitis B virus, IGIV",
author = "Daily, {Johanna P.} and B. Werner and R. Soiffer and J. Fingeroth",
year = "1998",
month = "4",
day = "1",
language = "English (US)",
volume = "21",
pages = "739--742",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - IGIV

T2 - A potential role for hepatitis B prophylaxis in the bone marrow peritransplant period

AU - Daily, Johanna P.

AU - Werner, B.

AU - Soiffer, R.

AU - Fingeroth, J.

PY - 1998/4/1

Y1 - 1998/4/1

N2 - Prevention of hepatitis B virus infection in transplant recipients can be difficult. Patients may be unresponsive to vaccination and intolerant of the intramuscular injections required to administer hepatitis B immune globulin (HBIG). A recipient of HBsAg-positive donor cells for a bone marrow transplant received multiple i.m. injections of HBIG. This mode of antibody delivery was limited by his thrombocytopenia and neutropenia and alternative forms of passive immunization were sought. Four lots of IGIV were investigated for anti-hepatitis B surface antibody (anti-HBs) content and all were found to contain significant antibody titer. Moreover, IGIV that was administered to four bone marrow transplant recipients for medical purposes unrelated to HBV transmission produced protective anti-HBs titers in all. These studies suggest IGIV may be useful for HBV prophylaxis in the appropriate setting or if HBIG is unavailable. The optimum regimen for HBV prevention in distinct transplant settings needs to be determined.

AB - Prevention of hepatitis B virus infection in transplant recipients can be difficult. Patients may be unresponsive to vaccination and intolerant of the intramuscular injections required to administer hepatitis B immune globulin (HBIG). A recipient of HBsAg-positive donor cells for a bone marrow transplant received multiple i.m. injections of HBIG. This mode of antibody delivery was limited by his thrombocytopenia and neutropenia and alternative forms of passive immunization were sought. Four lots of IGIV were investigated for anti-hepatitis B surface antibody (anti-HBs) content and all were found to contain significant antibody titer. Moreover, IGIV that was administered to four bone marrow transplant recipients for medical purposes unrelated to HBV transmission produced protective anti-HBs titers in all. These studies suggest IGIV may be useful for HBV prophylaxis in the appropriate setting or if HBIG is unavailable. The optimum regimen for HBV prevention in distinct transplant settings needs to be determined.

KW - Bone marrow transplant

KW - HBIG

KW - Hepatitis B virus

KW - IGIV

UR - http://www.scopus.com/inward/record.url?scp=0031899016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031899016&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 739

EP - 742

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 7

ER -